Skip to main content

Articles

Page 2 of 13

  1. Prostate Cancer (PCa) represents the second leading cause of cancer-related death in men. Prostate-specific antigen (PSA) serum testing, currently used for PCa screening, lacks the necessary sensitivity and sp...

    Authors: Caterina Gabriele, Federica Aracri, Licia Elvira Prestagiacomo, Maria Antonietta Rota, Stefano Alba, Giuseppe Tradigo, Pietro Hiram Guzzi, Giovanni Cuda, Rocco Damiano, Pierangelo Veltri and Marco Gaspari
    Citation: Clinical Proteomics 2023 20:52
    Content type: Research Published on:

  2. The organ perfusion solution (perfusate), collected at clinically and temporally significant stages of the organ preservation and transplantation process, provides a valuable insight into the biological status...

    Authors: Corinna M. Snashall, Chris W. Sutton, Letizia Lo Faro, Carlo Ceresa, Rutger Ploeg and Sadr ul Shaheed
    Citation: Clinical Proteomics 2023 20:51
    Content type: Methodology Published on:

  3. Prostate cancer (PCa) is the second most common cancer in males worldwide. The risk stratification of PCa is mainly based on morphological examination. Here we analyzed the proteome of 667 tumor samples from 4...

    Authors: Rui Sun, Lingling Tan, Xuan Ding, Jun A, Zhangzhi Xue, Xue Cai, Sainan Li and Tiannan Guo
    Citation: Clinical Proteomics 2023 20:50
    Content type: Research Published on:

  4. The tyrosine kinase inhibitor sunitinib is an effective first-line treatment for patients with advanced renal cell carcinoma (RCC). Hypothesizing that a functional read-out by mass spectrometry-based (phospho, p-

    Authors: Hanneke van der Wijngaart, Robin Beekhof, Jaco C. Knol, Alex A. Henneman, Richard de Goeij-de Haas, Sander R. Piersma, Thang V. Pham, Connie R. Jimenez, Henk M. W. Verheul and Mariette Labots
    Citation: Clinical Proteomics 2023 20:49
    Content type: Research Published on:

  5. Histones posttranslational modification represent an epigenetic mechanism that regulate gene expression and other cellular processes. Quantitative mass spectrometry used for the absolute quantification of such...

    Authors: Katarzyna Macur, Andrew Schissel, Fang Yu, Shulei Lei, Brenda Morsey, Howard S. Fox and Pawel Ciborowski
    Citation: Clinical Proteomics 2023 20:48
    Content type: Research Published on:

  6. Quantification of drug-target binding is critical for confirming that drugs reach their intended protein targets, understanding the mechanism of action, and interpreting dose-response relationships. For covale...

    Authors: Andrew G. Chambers, David C. Chain, Steve M. Sweet, Zifeng Song, Philip L. Martin, Matthew J. Ellis, Claire Rooney and Yeoun Jin Kim
    Citation: Clinical Proteomics 2023 20:47
    Content type: Research Published on:

  8. Glioblastoma is one of the most malignant primary brain cancer. Despite surgical resection with modern technology followed by chemo-radiation therapy with temozolomide, resistance to the treatment and recurren...

    Authors: Narae Kang, Hyun Jeong Oh, Ji Hye Hong, Hyo Eun Moon, Yona Kim, Hyeon-Jeong Lee, Hophil Min, Hyeonji Park, Sang Hun Lee, Sun Ha Paek and Jonghwa Jin
    Citation: Clinical Proteomics 2023 20:45
    Content type: Research Published on:

    The Correction to this article has been published in Clinical Proteomics 2024 21:9

  9. The quest for understanding and managing the long-term effects of COVID-19, often referred to as Long COVID or post-COVID-19 condition (PCC), remains an active research area. Recent findings highlighted angiop...

    Authors: Eric Yamga, Antoine Soulé, Alain Piché, Amin Emad, Madeleine Durand and Simon Rousseau
    Citation: Clinical Proteomics 2023 20:44
    Content type: Correspondence Published on:

  10. Systemic lupus erythematosus (SLE) is an autoimmune disease with multiple organ involvement, especially the kidneys. However, the underlying mechanism remains unclear, and accurate biomarkers are still lacking...

    Authors: He Huang, Yukun Zhang, Lan Gui, Li Zhang, Minglong Cai and Yujun Sheng
    Citation: Clinical Proteomics 2023 20:43
    Content type: Research Published on:

  11. Serological diagnostics is generally defined as the detection of specific human immunoglobulins developed against viral, bacterial, or parasitic diseases. Serological tests facilitate the detection of past inf...

    Authors: Jonathan Walter, Zicki Eludin and Andrei P. Drabovich
    Citation: Clinical Proteomics 2023 20:42
    Content type: Review Published on:

  12. Meningiomas are the most prevalent primary brain tumors. Due to their increasing burden on healthcare, meningiomas have become a pivot of translational research globally. Despite many studies in the field of d...

    Authors: Ankit Halder, Deeptarup Biswas, Aparna Chauhan, Adrita Saha, Shreeman Auromahima, Deeksha Yadav, Mehar Un Nissa, Gayatri Iyer, Shashwati Parihari, Gautam Sharma, Sridhar Epari, Prakash Shetty, Aliasgar Moiyadi, Graham Roy Ball and Sanjeeva Srivastava
    Citation: Clinical Proteomics 2023 20:41
    Content type: Research Published on:

  13. Cardiac troponin is a complex protein consisting of the three subunits I, T and C located in heart muscle cells. When the heart muscle is damaged, it is released into the blood and can be detected. Cardiac tro...

    Authors: Meltem Asicioglu, Merve Oztug and Nevin Gul Karaguler
    Citation: Clinical Proteomics 2023 20:40
    Content type: Research Published on:

  14. Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors. New drug targets and proteins that would assist sensitive PPGL imagining could improve therapy and quality of life of patients with ...

    Authors: Ondrej Vit, Pavel Talacko, Zdenek Musil, Igor Hartmann, Karel Pacak and Jiri Petrak
    Citation: Clinical Proteomics 2023 20:39
    Content type: Research Published on:

  15. Type 1 diabetes (T1D) results from an autoimmune attack of the pancreatic β cells that progresses to dysglycemia and symptomatic hyperglycemia. Current biomarkers to track this evolution are limited, with deve...

    Authors: Soumyadeep Sarkar, Emily C. Elliott, Hayden R. Henry, Ivo Díaz Ludovico, John T. Melchior, Ashley Frazer-Abel, Bobbie-Jo Webb-Robertson, W. Sean Davidson, V. Michael Holers, Marian J. Rewers, Thomas O. Metz and Ernesto S. Nakayasu
    Citation: Clinical Proteomics 2023 20:38
    Content type: Review Published on:

  16. Differentiating between a normal intrauterine pregnancy (IUP) and abnormal conditions including early pregnancy loss (EPL) or ectopic pregnancy (EP) is a major clinical challenge in early pregnancy. Currently,...

    Authors: Lynn A. Beer, Xiangfan Yin, Jianyi Ding, Suneeta Senapati, Mary D. Sammel, Kurt T. Barnhart, Qin Liu, David W. Speicher and Aaron R. Goldman
    Citation: Clinical Proteomics 2023 20:37
    Content type: Research Published on:

  17. The molecular pathology of diffuse large B cell lymphoma (DLBCL) has been extensively studied. Among DLBCL subtypes, the prognosis of CD5-positive DLBCL is worse than that of CD5-negative DLBCL, considering th...

    Authors: Takuya Hiratsuka, Shinji Ito, Rika Sakai, Tomoyuki Yokose, Tatsuya Endo, Yataro Daigo, Yohei Miyagi and Tatsuaki Tsuruyama
    Citation: Clinical Proteomics 2023 20:36
    Content type: Research Published on:

  18. Lymph node metastasis (LNM) and lymphatic vasculature space infiltration (LVSI) in cervical cancer patients indicate a poor prognosis, but satisfactory methods for diagnosing these phenotypes are lacking. This...

    Authors: Sai Han, Xiaoli Liu, Shuang Ju, Wendi Mu, Gulijinaiti Abulikemu, Qianwei Zhen, Jiaqi Yang, Jingjing Zhang, Yi Li, Hongli Liu, Qian Chen, Baoxia Cui, Shuxia Wu and Youzhong Zhang
    Citation: Clinical Proteomics 2023 20:35
    Content type: Research Published on:

  20. Multiple sclerosis (MS) remains a highly unpredictable disease. Many hope that fluid biomarkers may contribute to better stratification of disease, aiding the personalisation of treatment decisions, ultimately...

    Authors: Dorsa Sohaei, Simon Thebault, Lisa M. Avery, Ihor Batruch, Brian Lam, Wei Xu, Rubah S. Saadeh, Isobel A. Scarisbrick, Eleftherios P. Diamandis, Ioannis Prassas and Mark S. Freedman
    Citation: Clinical Proteomics 2023 20:33
    Content type: Research Published on:

  22. Human plasma contains a wide variety of circulating proteins. These proteins can be important clinical biomarkers in disease and also possible drug targets. Large scale genomics studies of circulating proteins...

    Authors: Corinne Carland, Grace Png, Anders Malarstig, Pik Fang Kho, Stefan Gustafsson, Karl Michaelsson, Lars Lind, Emmanouil Tsafantakis, Maria Karaleftheri, George Dedoussis, Anna Ramisch, Erin Macdonald-Dunlop, Lucija Klaric, Peter K. Joshi, Yan Chen, Hanna M. Björck…
    Citation: Clinical Proteomics 2023 20:31
    Content type: Research Published on:

  23. The detection of SARS-CoV-2 biomarkers by real time PCR (rRT-PCR) has shown that the sensitivity of the test is negatively affected by low viral loads and the severity of the disease. This limitation can be ov...

    Authors: Lina M. Marin, George S. Katselis, Paulos Chumala, Stephen Sanche, Lucas Julseth, Erika Penz, Robert Skomro and Walter L. Siqueira
    Citation: Clinical Proteomics 2023 20:30
    Content type: Research Published on:

  24. Systemic lupus erythematosus (SLE) is a clinically and biologically heterogenous autoimmune disease. We aimed to investigate the plasma proteome of patients with active SLE to identify novel subgroups, or endo...

    Authors: Kevin Y. C. Su, John A. Reynolds, Rachel Reed, Rachael Da Silva, Janet Kelsall, Ivona Baricevic-Jones, David Lee, Anthony D. Whetton, Nophar Geifman, Neil McHugh and Ian N. Bruce
    Citation: Clinical Proteomics 2023 20:29
    Content type: Research Published on:

  25. Non-muscle-invasive bladder cancer (NMIBC) has a high recurrence rate and muscle-invasive bladder cancer (MIBC) has unfavorable outcomes in urothelial bladder cancer (UBC) patients. Complex UBC-related protein...

    Authors: Samira Tabaei, Mohammad Reza Haghshenas, Ali Ariafar, Kambiz Gilany, Allan Stensballe, Shirin Farjadian and Abbas Ghaderi
    Citation: Clinical Proteomics 2023 20:28
    Content type: Research Published on:

  26. Within healthy dietary patterns, manipulation of the proportion of macronutrient can reduce CVD risk. However, the biological pathways underlying healthy diet-disease associations are poorly understood. Using ...

    Authors: Hyunju Kim, Alice H. Lichtenstein, Peter Ganz, Edgar R. Miller III, Josef Coresh, Lawrence J. Appel and Casey M. Rebholz
    Citation: Clinical Proteomics 2023 20:27
    Content type: Research Published on:

  27. We have developed a rapid and highly specific assay for detecting and monitoring SARS-CoV-2 infections by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). As MALDI-T...

    Authors: Lydia Kollhoff, Marc Kipping, Manfred Rauh, Uta Ceglarek, Günes Barka, Frederik Barka and Andrea Sinz
    Citation: Clinical Proteomics 2023 20:26
    Content type: Research Published on:

  28. Close to three-quarters of ovarian cancer cases are frequently diagnosed at an advanced stage, with more than 70% of them failing to respond to primary therapy and relapsing within 5 years. There is an urgent ...

    Authors: Jin Song, Lori J. Sokoll, Zhen Zhang and Daniel W. Chan
    Citation: Clinical Proteomics 2023 20:25
    Content type: Research Published on:

  29. Immune thrombocytopenia (ITP) is a common autoimmune disease characterized by loss of immune tolerance to platelet autoantigens leading to excessive destruction and insufficient production of platelets.

    Authors: Dong-mei Yin, Dai Yuan, Rui-jie Sun, Hong-zhi Xu, Shou-yong Hun, Xiao-hui Sui and Ning-ning Shan
    Citation: Clinical Proteomics 2023 20:24
    Content type: Research Published on:

  30. Molecular components in blood, such as proteins, are used as biomarkers to detect or predict disease states, guide clinical interventions and aid in the development of therapies. While multiplexing proteomics ...

    Authors: Camilla Johansson, Helian Hunt, Mirko Signorelli, Fredrik Edfors, Andreas Hober, Anne-Sophie Svensson, Hanna Tegel, Björn Forstström, Annemieke Aartsma-Rus, Erik Niks, Pietro Spitali, Mathias Uhlén and Cristina Al-Khalili Szigyarto
    Citation: Clinical Proteomics 2023 20:23
    Content type: Research Published on:

  31. Unpredictable treatment responses have been an obstacle for the successful management of rheumatoid arthritis. Although numerous serum proteins have been proposed, there is a lack of integrative survey to comp...

    Authors: Shuo-Fu Chen, Fu-Chiang Yeh, Ching-Yun Chen and Hui-Yin Chang
    Citation: Clinical Proteomics 2023 20:22
    Content type: Review Published on:

  32. IgA nephropathy (IgAN) and IgA vasculitis with nephritis (IgAVN) are related glomerular diseases characterized by marked similarities in immunological and histological findings. We herein performed a comparati...

    Authors: Hajime Kaga, Hirotoshi Matsumura, Ayano Saito, Masaya Saito, Fumito Abe, Takehiro Suzuki, Naoshi Dohmae, Masafumi Odaka, Atsushi Komatsuda, Hideki Wakui and Naoto Takahashi
    Citation: Clinical Proteomics 2023 20:21
    Content type: Research Published on:

  33. Sepsis is a common worldwide health condition with high mortality. It is caused by a dysregulated immune response to the pathogen. Severe infections resulting in sepsis can be also determined by monitoring sev...

    Authors: Josef Dvorak, Jana Novakova, Lucie Kraftova, Vendula Studentova, Martin Matejovic, Jaroslav Radej, Thomas Karvunidis, Jan Horak, Marcela Kralovcova, Jaroslav Hrabak, Zuzana Kalaninova, Michael Volny, Petr Novak and Petr Pompach
    Citation: Clinical Proteomics 2023 20:20
    Content type: Research Published on:

  34. Halting progression of chronic kidney disease (CKD) to established end stage kidney disease is a major goal of global health research. The mechanism of CKD progression involves pro-inflammatory, pro-fibrotic, ...

    Authors: Carlos R. Ramírez Medina, Ibrahim Ali, Ivona Baricevic-Jones, Aghogho Odudu, Moin A. Saleem, Anthony D. Whetton, Philip A. Kalra and Nophar Geifman
    Citation: Clinical Proteomics 2023 20:19
    Content type: Research Published on:

    The Correction to this article has been published in Clinical Proteomics 2024 21:25

  36. Proteomic analysis of human plasma by LC–ESI–MS/MS has discovered a limited number of new cellular protein biomarkers that may be confirmed by independent biochemical methods. Analysis of COVID-19 plasma has i...

    Authors: Zhuo Zhen Chen, Lloyd Johnson, Uriel Trahtemberg, Andrew Baker, Saaimatul Huq, Jaimie Dufresne, Peter Bowden, Ming Miao, Ja-An Ho, Cheng-Chih Hsu, Claudia C. dos Santos and John G. Marshall
    Citation: Clinical Proteomics 2023 20:17
    Content type: Research Published on:

  37. Authors: Dilana E. Staudt, Heather C. Murray, David A. Skerrett-Byrne, Nathan D. Smith, M. Fairuz B. Jamaluddin, Richard G. S. Kahl, Ryan J. Duchatel, Zacary P. Germon, Tabitha McLachlan, Evangeline R. Jackson, Izac J. Findlay, Padraic S. Kearney, Abdul Mannan, Holly P. McEwen, Alicia M. Douglas, Brett Nixon…
    Citation: Clinical Proteomics 2023 20:16
    Content type: Correction Published on:

    The original article was published in Clinical Proteomics 2022 19:48

  38. Colorectal cancer (CRC) is one of the major causes of cancer-related death worldwide. Although commercial biomarkers of CRC are currently available, they are still lacking in terms of sensitivity and specifici...

    Authors: Chris Verathamjamras, Juthamard Chantaraamporn, Thiwaree Sornprachum, Photsathorn Mutapat, Daranee Chokchaichamnankit, Kanokwan Mingkwan, Virat Luevisadpibul, Chantragan Srisomsap, Somchai Chutipongtanate, Jisnuson Svasti and Voraratt Champattanachai
    Citation: Clinical Proteomics 2023 20:15
    Content type: Research Published on:

  39. Clinical bronchoalveolar lavage fluid (BALF) samples are rich in biomolecules, including proteins, and useful for molecular studies of lung health and disease. However, mass spectrometry (MS)-based proteomic a...

    Authors: Danielle O. Weise, Monica E. Kruk, LeeAnn Higgins, Todd W. Markowski, Pratik D. Jagtap, Subina Mehta, Alan Mickelson, Laurie L. Parker, Christine H. Wendt and Timothy J. Griffin
    Citation: Clinical Proteomics 2023 20:14
    Content type: Methodology Published on:

  40. SARS-CoV-2 has been shown to predominantly infect the airways and the respiratory tract and too often have an unpredictable and different pathologic pattern compared to other respiratory diseases. Current clin...

    Authors: Gabriel Hirdman, Embla Bodén, Sven Kjellström, Carl-Johan Fraenkel, Franziska Olm, Oskar Hallgren and Sandra Lindstedt
    Citation: Clinical Proteomics 2023 20:13
    Content type: Research Published on:

  41. Gliomas are among the most malignant tumors, with a very poor prognosis. Early diagnosis is highly desirable since it can help implement more effective treatments for smaller tumors, which have not yet extensi...

    Authors: Atefeh Ghorbani, Lisa M. Avery, Dorsa Sohaei, Andrea Soosaipillai, Maxime Richer, Craig Horbinski, Katy McCortney, Wei Xu, Eleftherios P. Diamandis and Ioannis Prassas
    Citation: Clinical Proteomics 2023 20:12
    Content type: Research Published on:

  42. Salivary stones, also known as sialoliths, are formed in a pathological situation in the salivary glands. So far, neither the mechanism of their formation nor the factors predisposing to their formation are kn...

    Authors: Natalia Musiał, Aleksandra Bogucka, Dmitry Tretiakow, Andrzej Skorek, Jacek Ryl and Paulina Czaplewska
    Citation: Clinical Proteomics 2023 20:11
    Content type: Research Published on:

  43. Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma with poor prognosis in children. The 5-year survival rate for early RMS has improved, whereas it remains unsatisfactory for advanced patients. Urin...

    Authors: Na Xu, Yuncui Yu, Chao Duan, Jing Wei, Wei Sun, Chiyi Jiang, Binglin Jian, Wang Cao, Lulu Jia and Xiaoli Ma
    Citation: Clinical Proteomics 2023 20:10
    Content type: Research Published on:

  44. Aspiration pneumonia (AP), which is a major cause of death in the elderly, does present with typical symptoms in the early stages of onset, thus it is difficult to detect and treat at an early stage. In this s...

    Authors: Kohei Ogura, Maho Endo, Takashi Hase, Hitomi Negami, Kohsuke Tsuchiya, Takumi Nishiuchi, Takeshi Suzuki, Kazuhiro Ogai, Hiromi Sanada, Shigefumi Okamoto and Junko Sugama
    Citation: Clinical Proteomics 2023 20:9
    Content type: Research Published on:

  45. Gallbladder cancer (GBC) is a lethal cancer with a poor prognosis. The lack of specific and sensitive biomarkers results in delayed diagnosis with most patients presenting at late stages of the disease. Furth...

    Authors: Pavan Baichan, Previn Naicker, Tanya Nadine Augustine, Martin Smith, Geoffrey Candy, John Devar and Ekene Emmanuel Nweke
    Citation: Clinical Proteomics 2023 20:8
    Content type: Research Published on:

  46. RA is a common chronic and systemic autoimmune disease, and the diagnosis is based significantly on autoantibody detection. This study aims to investigate the glycosylation profile of serum IgG in RA patients ...

    Authors: Xiaoyue Deng, Xiaomin Liu, Yan Zhang, Dan Ke, Rui Yan, Qian Wang, Xinping Tian, Mengtao Li, Xiaofeng Zeng and Chaojun Hu
    Citation: Clinical Proteomics 2023 20:7
    Content type: Research Published on:

  47. Inflammatory bowel disease (IBD) encompasses a group of chronic relapsing disorders which include ulcerative colitis (UC) and Crohn’s disease (CD). The incidences of IBD and overweight/obesity are increasing i...

    Authors: Ping Yan, Yang Sun, Juan Luo, Xiaolin Liu, Jing Wu and Yinglei Miao
    Citation: Clinical Proteomics 2023 20:6
    Content type: Research Published on:

  48. We aimed to compare absolute plasma concentrations of N-terminal pro-brain natriuretic peptide (NT-proBNP) and growth differentiation factor 15 (GDF-15) obtained by a conventional immunoassay with the correspo...

    Authors: Emma Skau, Philippe Wagner, Jerzy Leppert, Johan Ärnlöv and Pär Hedberg
    Citation: Clinical Proteomics 2023 20:5
    Content type: Research Published on:

  49. Continuous renal replacement therapy (CRRT) has been considered as an adjuvant therapy for sepsis. However, the novel biomarker to evaluate the benefits of CRRT is limited. The aim of this study was to explore...

    Authors: Yun Cui, Shuyun Feng, Huijie Miao, Tiantian Liu, Jingyi Shi, Jiaying Dou, Chunxia Wang and Yucai Zhang
    Citation: Clinical Proteomics 2023 20:4
    Content type: Research Published on:

  50. Non-invasive detection of blood-based markers is a critical clinical need. Plasma has become the main sample type for clinical proteomics research because it is easy to obtain and contains measurable protein b...

    Authors: Xueting Ye, Xiaozhen Cui, Luobin Zhang, Qiong Wu, Xintong Sui, An He, Xinyou Zhang, Ruilian Xu and Ruijun Tian
    Citation: Clinical Proteomics 2023 20:3
    Content type: Research Published on:
Submit manuscript

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.8
    5-year Journal Impact Factor: 3.9
    Source Normalized Impact per Paper (SNIP): 0.831
    SCImago Journal Rank (SJR): 1.015

    Speed 2023
    Submission to first editorial decision (median days): 10
    Submission to acceptance (median days): 159

    Usage 2023
    Downloads: 434,196
    Altmetric mentions: 385

Clinical Proteomics

ISSN: 1559-0275